Literature DB >> 20497247

Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas.

Maximino Redondo1, Isabel Rodrigo, Julia Alcaide, Teresa Tellez, María J Roldan, Rafael Funez, Aurelio Diaz-Martin, Antonio Rueda, Eugenio Jiménez.   

Abstract

AIMS: It has been demonstrated that increased clusterin expression is involved in malignant progression and that anticlusterin treatment leads to selective apoptosis. The aim of this study was to determine the clinicopathological significance of clusterin expression in human colorectal carcinomas. METHODS AND
RESULTS: The expression of clusterin was examined in 31 adenomas and 103 colorectal carcinomas. Normal epithelial cells were always negative for clusterin expression, but clusterin expression was present in 16% (5/31) of adenomas and this percentage increased in colorectal carcinomas (30%, 31/103). Immunopositivity always presented an apical cytoplasmic pattern. The expression level of clusterin did not correlate with age, gender, grade or stage. However, its expression was significantly associated with a decrease in disease-free survival (P < 0.05). In a multivariate Cox proportional hazards model, clusterin expression remained a significant independent predictor.
CONCLUSIONS: Clusterin expression may have a role in colonic carcinogenesis and may help identify patients with more aggressive tumours who may benefit from targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497247     DOI: 10.1111/j.1365-2559.2010.03565.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

1.  Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.

Authors:  A Radziwon-Balicka; C Medina; L O'Driscoll; A Treumann; D Bazou; I Inkielewicz-Stepniak; A Radomski; H Jow; M W Radomski
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.

Authors:  Miao Xu; Xiumei Chen; Yanling Han; Chunqing Ma; Lin Ma; Shirong Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

Authors:  Hao Wang; Le Feng; Jian Wen Hu; Chun Lei Xie; Fang Wang
Journal:  Proteome Sci       Date:  2012-03-05       Impact factor: 2.480

4.  Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients.

Authors:  Yeng Chen; Siti Nuraishah Azman; Jesinda P Kerishnan; Rosnah Binti Zain; Yu Nieng Chen; Yin-Ling Wong; Subash C B Gopinath
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

5.  Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.

Authors:  Beny Shapiro; Piera Tocci; Gal Haase; Nancy Gavert; Avri Ben-Ze'ev
Journal:  Oncotarget       Date:  2015-10-27

6.  Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies.

Authors:  Jianzhong Zhang; Chenkui Miao; Aiming Xu; Kai Zhao; Zhiqiang Qin; Xiao Li; Chao Liang; Yibo Hua; Wei Chen; Chao Zhang; Yiyang Liu; Shifeng Su; Zengjun Wang; Bianjiang Liu
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

Review 7.  Apolipoproteins and cancer.

Authors:  Liwen Ren; Jie Yi; Wan Li; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Guanhua Du
Journal:  Cancer Med       Date:  2019-10-01       Impact factor: 4.452

8.  Clinical significance of clusterin expression in pancreatic adenocarcinoma.

Authors:  Junshuo Jin; Joon-Mee Kim; Yoon-Seok Hur; Won Pyo Cho; Keon-Young Lee; Seung-Ik Ahn; Kee Chun Hong; In-Sun Park
Journal:  World J Surg Oncol       Date:  2012-07-16       Impact factor: 2.754

9.  Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.

Authors:  Maria Braoudaki; George I Lambrou; Konstantinos Vougas; Kalliopi Karamolegou; George T Tsangaris; Fotini Tzortzatou-Stathopoulou
Journal:  J Hematol Oncol       Date:  2013-07-12       Impact factor: 17.388

10.  Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment.

Authors:  Rebekah M Engel; Wing Hei Chan; David Nickless; Sara Hlavca; Elizabeth Richards; Genevieve Kerr; Karen Oliva; Paul J McMurrick; Thierry Jardé; Helen E Abud
Journal:  J Clin Med       Date:  2020-01-02       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.